VUZI vs WRAP vs AXON vs MVIS

For growth investors, Vuzix Corporation (VUZI) is the stronger pick with 1090% revenue growth year-over-year, versus -74.

3% for MicroVision, Inc. (MVIS). Axon Enterprise, Inc. (AXON) offers the better valuation at 282. 7x trailing P/E (55. 0x forward), making it the more compelling value choice. Analysts rate Vuzix Corporation (VUZI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Axon Enterprise, Inc.

(AXON) delivered a total return of +216. 8%, compared to -95. 6% for MicroVision, Inc. (MVIS). Over 10 years, the gap is even starker: AXON returned +22. 0% versus WRAP's -71. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Axon Enterprise, Inc.

(AXON) is the lower-risk stock at 1. 19β versus Vuzix Corporation's 3. 40β — meaning VUZI is approximately 185% more volatile than AXON relative to the S&P 500. On balance sheet safety, Vuzix Corporation (VUZI) carries a lower debt/equity ratio of 4% versus 66% for MicroVision, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Vuzix Corporation (VUZI) is pulling ahead at 1090% versus -74.

3% for MicroVision, Inc. (MVIS). On earnings-per-share growth, the picture is similar: Vuzix Corporation grew EPS 61. 1% year-over-year, compared to -68. 5% for Axon Enterprise, Inc.. Over a 3-year CAGR, VUZI leads at 709. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Axon Enterprise, Inc.

(AXON) is the more profitable company, earning 4. 5% net margin versus -78. 6% for MicroVision, Inc. — meaning it keeps 4. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AXON leads at -2. 2% versus -57. 4% for MVIS. At the gross margin level — before operating expenses — AXON leads at 59. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for MVIS: 711.

7% to $5. 00.

In this comparison, VUZI (10.

1% yield), WRAP (1. 5% yield) pay a dividend. AXON, MVIS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Axon Enterprise, Inc.

(AXON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 19)). MicroVision, Inc. (MVIS) carries a higher beta of 2. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AXON: +22. 0%, MVIS: -66. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VUZI (Technology) and WRAP (Technology) and AXON (Industrials) and MVIS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VUZI is a small-cap high-growth stock; WRAP is a small-cap high-growth stock; AXON is a mid-cap high-growth stock; MVIS is a small-cap quality compounder stock. VUZI, WRAP pay a dividend while AXON, MVIS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.